<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01420913</url>
  </required_header>
  <id_info>
    <org_study_id>YCD207</org_study_id>
    <nct_id>NCT01420913</nct_id>
  </id_info>
  <brief_title>Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects</brief_title>
  <official_title>Randomized,Open-label,Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuhan Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yuhan Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to compare the pharmacokinetic characteristics of YHD1119 A,
      YHD1119 B, YHD1119 C and Lyrica capsule.

      YHD1119 A, B, C are controlled released formulations which are made by YUHAN Corporation.

      Primary endpoints are C max,ss and AUC tau. Secondary endpoints are AUC last, AUC infinity, T
      max,ss, t 1/2
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax,ss</measure>
    <time_frame>36 hr</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>AUCtau</measure>
    <time_frame>36 hr</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety monitoring</measure>
    <time_frame>14 days</time_frame>
    <description>Laboratory findings Adverse event</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUClast AUCinfinity Tmax,ss t1/2</measure>
    <time_frame>36 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUCinfinity</measure>
    <time_frame>36 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax,ss</measure>
    <time_frame>36 hr</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>t 1/2</measure>
    <time_frame>36 hr</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Lyrica capsule(Pregabalin 150mg)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>YHD1119 A(Pregabalin SR 300mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>YHD1119 B(Pregabalin SR 300mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>YHD1119 C(Pregabalin SR 300mg)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregabalin 300mg a day</description>
    <arm_group_label>Lyrica capsule(Pregabalin 150mg)</arm_group_label>
    <arm_group_label>YHD1119 A(Pregabalin SR 300mg)</arm_group_label>
    <arm_group_label>YHD1119 B(Pregabalin SR 300mg)</arm_group_label>
    <arm_group_label>YHD1119 C(Pregabalin SR 300mg)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20~45 years old, healthy adult male subject

          -  &gt;55 Kg(Body weight) and &lt; ideal body weight Â± 20%

        Exclusion Criteria:

          -  AST or ALT &gt; 1.25 * Upper normal range (Lab)

          -  Total bilirubin &gt; 1.5 * Upper normal range

          -  Systolic BP &gt;140 OR &lt;100, Diastolic BP &gt;90 OR &lt;65
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul ST.Mary Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2011</study_first_submitted>
  <study_first_submitted_qc>August 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2011</study_first_posted>
  <last_update_submitted>August 19, 2011</last_update_submitted>
  <last_update_submitted_qc>August 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

